NCT06497790 BJH-SDS Validation of the German Translation
| NCT ID | NCT06497790 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Giessen |
| Condition | Dysphagia |
| Study Type | OBSERVATIONAL |
| Enrollment | 570 participants |
| Start Date | 2024-04-15 |
| Primary Completion | 2026-04-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 570 participants in total. It began in 2024-04-15 with a primary completion date of 2026-04-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The first object of the study is the validation of a translation of the Barnes-Jewish Hospital Stroke Dysphagia Screen with determination of sensitivity, specificity, interrater reliability (especially between different professional groups) and criterion validity. If the German translation proves to be suitable, it will also be validated on general neurological patients, i.e. patients on a neurological ward without a stroke.
Eligibility Criteria
Inclusion Criteria: * All stroke patients in the neurology department of the Lahn-Dill Clinic in Wetzlar and the stroke unit of the Bürgerhospital in Friedberg and the neurologic ICU of the University Hospital in Giessen are to be screened with the BJH-SDS-G after appropriate information has been provided. Exclusion Criteria: * Exclusion criteria are a lack of informed consent, contraindications to an FEES examination, a history of stroke, pre-existing dysphagia or a disease that may be associated with dysphagia (e.g. ENT tumors, Parkinson's disease, neuromuscular diseases).
Contact & Investigator
Tobias Braun, PD MD
STUDY DIRECTOR
University of Giessen
Frequently Asked Questions
Who can join the NCT06497790 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Dysphagia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06497790 currently recruiting?
Yes, NCT06497790 is actively recruiting participants. Contact the research team at tobias.braun@neuro.med.uni-giessen.de for enrollment information.
Where is the NCT06497790 trial being conducted?
This trial is being conducted at Giesen, Germany.
Who is sponsoring the NCT06497790 clinical trial?
NCT06497790 is sponsored by University of Giessen. The principal investigator is Tobias Braun, PD MD at University of Giessen. The trial plans to enroll 570 participants.